203 top medical experts on Lymphangiosarcoma across 15 countries and 13 U.S. states, including 32 MDs (Physicians). This is based on an objective analysis of their Scientific Publications, Clinical Trials, Medicare, and NIH Grants.

  1. Lymphangiosarcoma: A malignant tumor originating from the endothelial cells of lymphatic vessels. Most lymphangiosarcomas arise in an arm secondary to radical mastectomy but they sometimes complicate idiopathic lymphedema. The lymphedema has usually been present for 6 to 10 years before malignant changes develop. (From Dorland, 27th ed; Holland et al., Cancer Medicine, 3d ed, p1866)
  2. Clinical guidelines are the recommended starting point to understand initial steps and current protocols in any disease or procedure:
  3. Broader Categories (#Experts): Lymphatic Vessel Tumors (20), Sarcoma (3,723).
  4. Clinical Trials ClinicalTrials.gov : at least 1 including 1 Active
  5. Synonyms: Malignant Lymphangioendothelioma


  

        

                    


    Computing Expert Listing ...

);